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Abstract
Background: Migraine is a multifactorial disorder with complex neuronal and vascular mechanisms that
encompasses a wide clinical spectrum of symptoms, including ocular manifestations. Dry eye disease and
dysfunction of ocular somatosensory pathways have been implicated in the pathogenesis. The current study
investigates the association between a dysfunctional tear film and ocular aberrations with migraine.
Methods: Sixty eyes of 30 patients with migraine and 60 eyes of 30 controls were studied. Dry eye evaluation
included Schirmer’s test, tear film break-up time, corneal esthesiometry and lipid layer analysis using Lipiview®
interferometer. Wavefront aberrations were measured using Optical Path Difference before performing the dry eye
evaluation. The intraocular light scatter was quantified using the objective scatter index (OSI) of the optical quality
analysis system. Measured parameters were compared between the migraine and the control group using
independent sample t-test. Statistical analysis was performed using commercial software. A p value of≤ 0.05 was
considered statistically significant.
Results: There were 19 females and 11 males in each group. Statistically significant difference was found between
the two groups with respect to total aberrations (p = 0.049), higher order aberrations (p = 0.009), coma (p = 0.03),
spherical aberrations (p = 0.018), Lipiview interferometric coloric units (p < 0.001) and OSI (p < 0.001). Trefoil (p = 0.26)
and TBUT (p = 0.398) were not significantly different between both groups.
Conclusions: Ocular aberrations are higher in patients with migraine as compared with controls. Tear film
abnormalities add to the aberrations in otherwise asymptomatic patients and may also be associated with
migraineous attacks. Treating the ocular surface to obtain a healthy tear film might introduce a potential modifiable
factor in the prevention of migraneous attacks.
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Background
The relationship between the eye and migraine is an in-
teresting one. Ocular effects of migraine involve the eye-
lids, pupil, optical nerve, retina, extraocular muscles and
migraneous ocular pain [1]. The most common migraine
aura is visual in nature [2]. Undiagnosed migraineurs
may first present for an eye examination looking for
answers to their ocular symptoms [3], including photo-
phobia or intolerance to light, which are also seen in
other ocular diseases [4–6].
The tear film is the first and most important refractive
surface of the eye [7]. An unhealthy ocular surface can
lead to increased tear film break-up and hence result in
image degradation secondary to increased wavefront aber-
rations [8]. Imperfections in the optical system that occur
due to irregularities of the optical surfaces and differences
in the refractive indices are called aberrations. Changes in
the visual environment that lead to evaporative dry eye
and alterations in the ocular surface may influence aberra-
tions. Dry eye disease is also noted to be more frequent in
migraine patients with a greater presence of aura, longer
duration of attacks and longer disease durations [9]. The
trigeminal nerve is the common afferent nerve for the mi-
graine pathway as well as for dry eye associated ocular
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hyperalgesia [10, 11]. It is therefore interesting to explore
the role of eye disease in aggravating the migraine symp-
toms. The current study looks at the correlation between
migraine and a dysfunctional tear film as well as ocular
aberrations in migraine patients as well as controls.
Chronic migraine is characterized by headaches occur-
ring for 15 or more days in a month [12]. With a preva-
lence of 0.5-2%, the conversion to chronic migraine is
approximately 2.5% every year [12, 13]. Several factors
may be responsible for this negative evolution in the
course of migraine and hence it is worthwhile to identify
preventable or reversible factors. Hence, the current
study investigates the role of a dysfunctional tear film
and ocular aberrations in migraine by comparing ocular
aberrations, ocular scatter index (OSI) and the tear film
break-up time (TBUT) between controls and those with
migraine.
Methods
This non-interventional, observational cross sectional
study was approved by the hospital’s institutional review
board and was in agreement with the tenets of the
Declaration of Helsinki. All patients after having been
given a full explanation of the procedure provided a
written informed consent. Subjects aged 18–35 years,
spherical equivalent (SE) within ± 0.50 D without sys-
temic diseases associated with dry eye (e.g., rheumatoid
arthritis), any pre-existing ocular disorder or history of
ocular surgery served as controls. Patients with a con-
firmed diagnosis of chronic migraine with aura accord-
ing to international classification of headache disorders
were included in the study after neurological consult.
After a thorough clinical history to rule out ocular and
systemic co-morbidities, visual acuity assessment, refrac-
tion, detailed slit-lamp examination and fundus evalu-
ation were performed. Subjects were tested between
10:00 AM and 1:00 PM in a dimly lit consulting room
under ambient conditions of temperature and humidity.
Schirmer’s test without anesthetic (Schirmer’s I) was per-
formed using sterile Schirmer’s strips - Whatman filter
paper measuring 5 × 35-mm2 (Contacare Opthalmics
and Diagnostics, India) to rule out aqueous deficiency
dry eye disease. A hanging drop of 1% fluorescein stain
(Contacare Opthalmics and Diagnostics, India) was in-
stilled in the conjunctival cul-de-sac to note the TBUT
with corneal and conjunctival epithelial staining if any.
Corneal sensations were assessed in all patients with the
Cochet-Bonnet esthesiometer (Luneau ophthalmologia,
Chartes, France). The lipid layer of the tear film was ob-
jectively measured and quantified in interferometric col-
oric units (ICU) using the Lipiview® interferometer
(TearScience, Morrisville, N.C). Wavefront aberrations
in root mean square (RMS) were measured using the
mesopic wavefront by the Optical Path Difference
(OPDIII, Nidek, Japan) before performing the dry eye
evaluation mentioned above. The intraocular light scat-
ter was quantified using the OSI of the optical quality
analysis system (OQAS; Visiometrics, Terrassa, Spain)
based on the principle of double pass using a laser diode
wavelength of 780 nm. Measurements were taken after
correcting the manifest refractive cylinder using an ex-
ternal lens and the machine automatically corrects the
spherical error. The OSI was measured after 4–5 blinks
and then at 0.5-second intervals over 20 s without the
subject blinking in between.
The data was normally distributed and therefore the
measured parameters were compared between both
groups using the independent sample t-test. Statistical
analysis was performed using commercial software (Stata
ver. 12.1; StataCorp, College Station, TX). A p value of ≤
0.05 was considered statistically significant.
Results
Sixty eyes of 30 subjects with migraine (Group 1) and
60 eyes of 30 normal patients (Group 2) were enrolled
in this study. There were 19 females and 11 males in
each group. The mean age of subjects in Group 1 was
(24.93 ± 4.54) years and that in Group 2 was (26.8 ±
6.16) years. Table 1 shows the comparison of aberra-
tions and dry eye metrics between the two groups.
Total aberrations (p = 0.049), higher order aberrations
(p = 0.009), coma (p = 0.03), spherical aberrations (p =
0.018), Lipiview ICU (p < 0.001) and OSI (p < 0.001)
were significantly different between the two groups.
Trefoil (p = 0.26) and TBUT (p = 0.398) however, were
not significantly different between both groups. The
mean value of Schirmer’s test with anesthesia was
(16.5 ± 6.4) mm in Group 1 and (17.4 ± 4.2) mm in
Group 2, (p = 0.78). The mean corneal esthesiometry
Table 1 Aberrations (in microns) and dry eye evaluation data in








Total aberrations (RMS) 1.01 ± 0.34 1.20 ± 0.66 0.049*
Higher order aberrations (RMS) 0.38 ± 012 0.47 ± 0.03 0.009*
Coma (RMS) 0.20 ± 0.11 0.25 ± 0.13 0.030*
Trefoil (RMS) 0.23 ± 0.13 0.26 ± 0.16 0.260
Spherical aberration (RMS) 0.10 ± 0.06 0.16 ± 0.20 0.018*
Lipiview ICU 69.76 ± 5.20 63.18 ± 2.67 <0.001*
OSI 0.921 ± 0.14 1.26 ± 0.02 <0.001*
TBUT (seconds) 9.66 ± 1.51 9.41 ± 1.71 0.398
RMS = Root Mean Square; ICU = Interferometric Coloric Units; OSI = Ocular
Scatter Index; TBUT = Tear film break up time
n: sample size
*indicates a statistically significant difference between the two groups. A p-
value <0.05 was considered statistical significant
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was similar between Group 1 (5.76 ± 0.4) cm and
Group 2 (5.2 ± 0.8) cm, (p = 0.9).
Discussion
In this study, we looked at the correlation between mea-
sures of a dysfunctional tear film and migraine and com-
pared it with controls. The trigeminal nerve is the
common afferent for the migraine pathway as well as for
dry eye associated ocular hyperalgesia and may play a
role in the pathogenesis of ocular discomfort associated
with migraine [10, 11].
Optical aberrations are a cumulative characteristic of
the tear film, cornea and internal optics. It has been
shown that the normal values of higher order aberra-
tions may vary between various racial or ethnic groups
[14]. Aberrations, in the presence of a healthy tear film
are unlikely to change and are inherent to the patient’s
optical system. The quality of vision can be influenced
by inherent aberrations of the eye and/or those induced
by alterations in the normal ocular structures like tear
film abnormalities. All patient eyes included in our study
had a SE of −0.50 diopters or less with a best-corrected
distance visual acuity of 20/20 in each eye. However, the
presence of significantly high aberrations and a dysfunc-
tional tear film may play a role in degrading the quality
of the retinal image, thereby acting as triggers for mi-
graine. The association between dry eye and migraine
has been investigated earlier [9, 15, 16]. However, in the
current study, we did not include patients with
Schirmer’s test value <10 mm/5 min thereby ruling out
aqueous deficiency. This criteria for exclusion was ap-
plied because patients with frank dry eye will have in-
creased aberrations on wavefront measurement due to a
poor tear film layer, which in turn would lead to an erro-
neous overestimation of the individual’s aberration pro-
file. TBUT though abnormal, was not significantly
different in patient eyes compared to controls. Subjects
and controls were age and gender matched as these fac-
tors themselves can be associated with dry eye disease.
The reduced thickness of lipid layer causes the tear film
to break up thereby causing the incident light to scatter
as indicated by a significantly high OSI in eyes with mi-
graine. Patient eyes were found to have statistically sig-
nificant higher total, coma, spherical and higher order
aberrations. Therefore, patients with migraine have in-
herently high aberrations with intra-ocular scatter and it
is possible that a dysfunctional tear film may worsen the
visual symptoms and be associated with migraineous at-
tacks. An abnormal lipid layer as well as high aberrations
may potentially act as triggers in predisposed patients.
However, further studies with a larger cohort are re-
quired to establish this fact. To the best of our know-
ledge, the current study is the first study to study a
possible association between ocular aberrations and
migraine. Aberrometry thus has a potential role as a
screening tool to identify patients with ocular triggers
for migraine. This would also help classify patients who
need aggressive management of borderline ocular sur-
face dysfunction in an attempt to attenuate migraineous
attacks in susceptible patients.
The statistical analysis in our study was performed eye
wise rather than subject wise. We included both eyes of
all subjects in both groups for analysis. This may have
biased our results however, we feel that the inclusion of
both eyes and respective relevant parameters is import-
ant and they would together contribute towards the gen-
esis of a trigger. We also analyzed the data using one eye
of each participant randomly and the results were not
significantly different. The limitations of our study in-
clude need for a larger sample size. Also, the examin-
ation and measurements were performed in the non-
ictal phase. Studying ictal phase tear film changes and
aberrations will help us understand the potential role of
these ocular factors in precipitating an attack. Also, a
possible influence of the tear film dysfunction and aber-
rations on the duration, frequency and severity of migra-
neous attacks was not studied.
Conclusions
We found that ocular aberrations were higher among
patients with migraine as compared to controls and that
ocular surface disease in migraine adds to the aberra-
tions. This study demonstrates the association between
chronic migraine and dysfunctional tear film along with
ocular aberrations. Treating the ocular surface to obtain
a healthy tear film might introduce a potential modifi-
able factor that will help reduce the frequency and sever-
ity of migraneous attacks. Studies with longer follow-up
after treating the ocular surface will be needed to con-
firm our hypothesis.
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